losartan has been researched along with 1-methyl-4-phenylpyridinium in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chiueh, CC; de Oliveira, AM; Saavedra, JM; Viswanathan, M; Wu, RM | 1 |
Banninger, GP; Cantu, D; Das, M; Griffin, WS; Jones, SM; Marriott, B; Rachubinski, AL; Thornton, J; Zawada, WM | 1 |
2 other study(ies) available for losartan and 1-methyl-4-phenylpyridinium
Article | Year |
---|---|
[125I]CGP 42112 reveals a non-angiotensin II binding site in 1-methyl-4-phenylpyridine (MPP+)-induced brain injury.
Topics: 1-Methyl-4-phenylpyridinium; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Autoradiography; Binding Sites; Biphenyl Compounds; Brain; Brain Injuries; Imidazoles; Iodine Radioisotopes; Losartan; Male; Oligopeptides; Rats; Rats, Sprague-Dawley; Receptors, Angiotensin; Substantia Nigra; Tetrazoles | 1994 |
Generation of reactive oxygen species in 1-methyl-4-phenylpyridinium (MPP+) treated dopaminergic neurons occurs as an NADPH oxidase-dependent two-wave cascade.
Topics: 1-Methyl-4-phenylpyridinium; Angiotensin II Type 1 Receptor Blockers; Animals; Cell Line; Dopaminergic Neurons; Electron Transport Complex I; Female; Herbicides; Hydrogen Peroxide; Losartan; Mice; Mice, Inbred C57BL; NADPH Oxidases; Oxidants; Protein Subunits; Rats; Reactive Oxygen Species; RNA, Small Interfering; Substantia Nigra | 2011 |